Gabapentin bioavailability: effect of dose and frequency of administration in adult patients with epilepsy

Next »Epilepsy Research
Volume 31, Issue 2 , Pages 91-99, July 1998

Barry E. Gidal
- School of Pharmacy, University of Wisconsin, 425 N. Charter Street, Madison, WI 53706, USA
- Department of Neurology, University of Wisconsin, 425 N. Charter Street, Madison, WI 53706, USA
- Corresponding author. Tel.: +1 608 2623280; fax: +1 608 2655421; e-mail: beg@pharmacy.wisc.edu
John DeCerce
- University of Miami, International Center for Epilepsy, Miami, FL, USA
Howard N. Bockbrader
- Warner-Lambert Co., Parke-Davis Pharmaceutical Research Division, Ann Arbor, MI, USA
Jose Gonzalez
- University of Miami, International Center for Epilepsy, Miami, FL, USA
Sarah Kruger
- Department of Neurology, University of Wisconsin, 425 N. Charter Street, Madison, WI 53706, USA
Michael E. Pitterle
- School of Pharmacy, University of Wisconsin, 425 N. Charter Street, Madison, WI 53706, USA
Paul Rutecki
- Department of Neurology, University of Wisconsin, 425 N. Charter Street, Madison, WI 53706, USA
R.Eugene Ramsay
- University of Miami, International Center for Epilepsy, Miami, FL, USA